Search This Blog

Thursday, November 12, 2020

Biocept +4% on COVID-19 testing update

  • Biocept (NASDAQ:BIOC) provides an update on its COVID-19 testing with more than 100,000 samples received to date for processing through its RT-PCR technology.
  • The company provides COVID-19 test results within 48 hours of receiving a sample.
  • BIOC is providing COVID-19 testing to skilled nursing centers, hospitals, clinics and surgery centers.
  • "We expect COVID-19 RT-PCR testing will have a significant positive impact on our revenues through the remainder of the year and continuing into 2021," said Michael Nall, President and CEO.
  • https://seekingalpha.com/news/3635497-bioceptplus-4-on-covidminus-19-testing-update

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.